An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
OraSure Technologies, Inc. (NASDAQ: OSUR) will announce its first-quarter 2024 financial results and host an earnings call on May 8th, 2024. The conference call will cover financial results and business developments, with a webcast available on OraSure's investor relations page. Participants can pre-register for the live call via a provided link.
OraSure Technologies, Inc. (NASDAQ: OSUR) annuncerà i risultati finanziari del primo trimestre del 2024 e terrà una teleconferenza sugli utili l'8 maggio 2024. La conferenza tratterà i risultati finanziari e gli sviluppi aziendali, con una trasmissione web disponibile sulla pagina delle relazioni con gli investitori di OraSure. I partecipanti possono preregistrarsi per la chiamata in diretta tramite un link fornito.
OraSure Technologies, Inc. (NASDAQ: OSUR) anunciará los resultados financieros del primer trimestre de 2024 y llevará a cabo una llamada de resultados el 8 de mayo de 2024. La llamada de conferencia abordará los resultados financieros y los desarrollos empresariales, con una transmisión por web disponible en la página de relaciones con inversores de OraSure. Los participantes pueden preinscribirse para la llamada en vivo a través de un enlace proporcionado.
OraSure Technologies, Inc. (NASDAQ: OSUR)는 2024년 1분기 재무 결과를 발표하고 2024년 5월 8일에 실적 발표 전화 회의를 개최할 예정입니다. 이 전화 회의는 재무 결과와 비즈니스 개발을 다룰 것이며, OraSure의 투자자 관계 페이지에서 웹캐스트를 볼 수 있습니다. 참가자들은 제공된 링크를 통해 라이브 콜에 사전 등록할 수 있습니다.
OraSure Technologies, Inc. (NASDAQ: OSUR) annoncera ses résultats financiers pour le premier trimestre de 2024 et organisera un appel de résultats le 8 mai 2024. L'appel de conférence couvrira les résultats financiers et les développements commerciaux, avec une webdiffusion disponible sur la page des relations avec les investisseurs d'OraSure. Les participants peuvent se préinscrire pour l'appel en direct via un lien fourni.
OraSure Technologies, Inc. (NASDAQ: OSUR) wird seine Finanzergebnisse für das erste Quartal 2024 bekannt geben und am 8. Mai 2024 einen Ergebnisanruf durchführen. Der Konferenzanruf wird sich auf die Finanzergebnisse und Geschäftsentwicklungen konzentrieren, mit einem Webcast, der auf der Seite für Investor Relations von OraSure verfügbar ist. Teilnehmer können sich über einen bereitgestellten Link vorab für den Live-Anruf registrieren.
Positive
None.
Negative
None.
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certain business developments for 4:45 p.m. ET on Wednesday, May 8, 2024.
A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.
To participate in the live conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.
About OraSure Technologies, Inc. OraSure Technologies (the “Company”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. The Company improves access, quality, and value of healthcare with innovation in effortless tests, sample management solutions, and services. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass diagnostics, tools, and services. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.
When will OraSure announce its first-quarter 2024 financial results?
OraSure will announce its first-quarter 2024 financial results on May 8th, 2024.
What time is the earnings conference call scheduled for?
The earnings conference call is scheduled for 4:45 p.m. ET on Wednesday, May 8, 2024.
Where can I access the webcast of the conference call?
The webcast of the conference call will be available on the investor relations page of OraSure's website at https://orasure.gcs-web.com/events-and-presentations.
How long will the webcast be available for after the call?
The webcast will be archived on OraSure's website shortly after the call and will be available for approximately 90 days.
How can I participate in the live conference call?
To participate in the live conference call, pre-register via the provided link: https://register.vevent.com/register/BI6ea5c5c7630d4ba196be212024e8c2e6
based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo
